Physician profile
Daniel E Wesche
NPI 1013985191
$119,255.86
in general payments reported to CMS, 2019-2025
18 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $22K · 2021: $5,986 · 2022: $47K · 2023: $10K · 2024: $9,574 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,894 · Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,335.00 |
| Travel and Lodging | $1,893.59 |
| Food and Beverage | $1,672.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $79,045.71 | 2019-2025 | Synfix Evolution, Viper |
| Centinel Spine, LLC | $33,039.60 | 2020-2025 | Prodisc L |
| Depuy Synthes Products, INC. | $4,647.07 | 2019 | |
| Alphatec Spine, INC | $1,281.74 | 2023-2024 | Other - Miscellaneous, Solus Alif |
| Depuy Synthes Sales INC. | $547.20 | 2019-2022 | |
| Tela Bio, INC. | $220.46 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lifenet Health | $175.00 | 2023 | |
| Stryker Corporation | $71.70 | 2024-2025 | 1788 |
| Baxter Healthcare | $41.81 | 2024 | Seprafilm |
| Mimedx Group, INC. | $29.23 | 2024 | |
| Ethicon US, LLC | $25.48 | 2025 | Ethicon, Stratafix, Evarrest |
| Surgenex LLC | $24.18 | 2025 | Renograft, Pellograft, Surmatrix |
| Boston Scientific Corporation | $22.02 | 2025 | General - Vascular Intervention |
| 180 Medical, INC. | $19.86 | 2019 | |
| Dilon Technologies, INC. | $18.47 | 2024 | Hemoblast Bellows |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $17.48 | 2019 | |
| Covidien LP | $16.06 | 2019 | |
| Innocoll Pharmaceuticals Limited | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wesche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.